ARDX Ardelyx, Inc. - Common Stock
NASDAQ · Biotechnology · Wyświetl na SEC EDGAR ↗ zamknij Paź 2, 2026 10-K/10-Q Sie 6, 2026
$3,34
· % zakresu 52 tyg.
· powyżej minimum
· do maksimum
$3,2952tyg. minimum
$8,4052tyg. maksimum
Kapitalizacja Rynkowa (MRQ)
$832M
P/E (TTM)
-14.5
EPS (TTM)
$-0.23
Przychody (TTM)
$451M
Twoje odznaki
Zakres 52 tyg.
$3–$8
Ocena Analityków
STRONG BUY
Cena Docelowa
$13
P/E
-14.5
ROE
-38.6%
Marża Zysku Netto
-12.4%
Twój pasek odznak jest pusty — przypnij metrykę w dowolnym miejscu na tej stronie.
ARDX Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$3.34
Kapitalizacja Rynkowa (MRQ)
$832M
P/E (TTM)
-14.5
EPS (TTM)
$-0.23
Przychody (TTM)
$451M
ROE (TTM)
-38.6%
Zakres 52 tyg.
$3–$8
ARDX Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
zakres
kreski
Granularność słupków dostosowuje się do wybranego okresu — najedź kursorem na wykres, aby zobaczyć otwarcia/maksima/minima/zamknięcia dla danego słupka.
O Ardelyx, Inc. - Common Stock Przegląd firmy z Wikipedii
sektorHealthcare
branżaBiotechnology
pracownicy489
krajUS
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody$407M2017-12-31 → 2025-12-31
EPS$-0.262019-12-31 → 2025-12-31
Wolny przepływ pieniężny$-44M2016-12-31 → 2025-12-31
Marża netto-12.4%2017-12-31 → 2025-12-31
Wycena i wskaźniki
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
| Wskaźnik | Trend 5-letni | ARDX | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| P/E (TTM) | -14.5średnia z 5 lat ≈-16.1 | ≈-16.1 | · | · | |
| P/S (TTM) | 1.8średnia z 5 lat ≈8.7 | ≈8.7 | 5.4 | Niedowartościowany | |
| P/B (MRQ) | 5.6średnia z 5 lat ≈6.3 | ≈6.3 | 3.2 | Zawyżona wycena | |
| Cena / FCF (TTM) | -46.4średnia z 5 lat ≈-16.7 | ≈-16.7 | · | · | |
| Cena / Przepływy pieniężne (TTM) | -48.0średnia z 5 lat ≈-17.1 | ≈-17.1 | · | · | |
| Price / Tangible Book (Cena / Wartość księgowa materialna) | 4.9średnia z 5 lat ≈6.3 | ≈6.3 | · | · |
Mediana porównawcza jest obliczana na znormalizowanej podstawie dla każdej metryki i może nie zawsze odpowiadać podstawie TTM/MRQ pokazanej dla tej akcji.
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
| Wskaźnik | Trend 5-letni | ARDX | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Marża Operacyjna (TTM) | -7.9%średnia z 5 lat ≈-344.0% | ≈-344.0% | -1023.7% | Najwyższa półka | |
| Marża EBITDA (TTM) | -7.1%średnia z 5 lat ≈-343.1% | ≈-343.1% | -1023.7% | Najwyższa półka | |
| Marża przed opodatkowaniem (TTM) | -12.3%średnia z 5 lat ≈-354.9% | ≈-354.9% | · | · | |
| Marża Zysku Netto (TTM) | -12.4%średnia z 5 lat ≈-355.0% | ≈-355.0% | -971.4% | Najwyższa półka | |
| ROA (TTM) | -10.7%średnia z 5 lat ≈-36.1% | ≈-36.1% | -55.9% | Najwyższa półka | |
| ROE (TTM) | -38.6%średnia z 5 lat ≈-75.0% | ≈-75.0% | -65.6% | Najwyższa półka | |
| ROIC | -24.9%średnia z 5 lat ≈-66.2% | ≈-66.2% | -34.2% | Najwyższa półka |
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
| Wskaźnik | Trend 5-letni | ARDX | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Wskaźnik bieżący (MRQ) | 3.3średnia z 5 lat ≈3.7 | ≈3.7 | 4.4 | Poniżej średniej | |
| Quick Ratio (Wskaźnik Szybkości) | 1.6średnia z 5 lat ≈1.4 | ≈1.4 | 3.4 | Niska płynność |
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
| Wskaźnik | Trend 5-letni | ARDX | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Revenue YoY (Przychody R/R) | 22.1%średnia z 5 lat ≈155.7% | ≈155.7% | · | · | |
| Revenue CAGR 3Y (Przychody CAGR 3L) | 98.4%średnia z 5 lat ≈157.9% | ≈157.9% | · | · | |
| Revenue CAGR 5Y (Przychody CAGR 5L) | 121.9% | · | · | · |
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
| Wskaźnik | Trend 5-letni | ARDX | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Asset Turnover (Rotacja aktywów) | 0.9średnia z 5 lat ≈0.5 | ≈0.5 | 0.5 | Najwyższa półka | |
| Inventory Turnover (Rotacja zapasów) | 0.4średnia z 5 lat ≈0.5 | ≈0.5 | · | · | |
| Receivables Turnover (Rotacja należności) | 6.3średnia z 5 lat ≈15.2 | ≈15.2 | · | · | |
| Revenue / Employee (Przychody / pracownika) | ≈$833.0K | · | · | · |
wartość · ≈ średnia z 5 lat · mediana branżowa · werdykt względem mediany
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
-2.3%
Następny raport
Paź 28, 2026
| Okres | Raport | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|---|
| 30 czerwca 2026 | Sie 3, 2026 | $-0.07 | $-0.07 | -7.0% |
| 31 marca 2026 | $-0.15 | $-0.15 | -1.4% | |
| 31 grudnia 2025 | $0.00 | $0.01 | -100.0% | |
| 30 września 2025 | $0.00 | $-0.06 | 100.0% | |
| 30 czerwca 2025 | $-0.08 | $-0.14 | 41.3% | |
| 31 marca 2025 | $-0.17 | $-0.12 | -46.7% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $407M | $334M | $124M | $52M | $10M | $8M | $5M | $3M | $42M | · | $24M | $32M | |
| Cost of Revenue | $40M | $51M | $18M | $4M | $1M | $145.0K | $600.0K | $466.0K | $8M | · | · | · | |
| Gross Profit | · | · | · | · | · | · | $5M | $2M | $34M | · | $24M | · | |
| R&D Expense | $72M | $52M | $36M | $35M | $91M | $65M | $72M | $69M | $75M | $94M | $40M | $26M | |
| SG&A Expense | $337M | $259M | $134M | $77M | $72M | $33M | $24M | $24M | $23M | $19M | $14M | $7M | |
| Operating Expenses | $448M | $362M | $188M | $112M | $163M | $98M | $97M | $94M | $99M | $113M | $53M | $33M | |
| Operating Income | $-41M | $-28M | $-63M | $-64M | $-154M | $-91M | $-91M | $-91M | $-65M | $-113M | $-29M | $-2M | |
| Interest Expense | · | · | $5M | $3M | $5M | $5M | $6M | $4M | · | · | · | · | |
| Other Non-op | $9M | $9M | $7M | $2M | $687.0K | $2M | $2M | $3M | $2M | $508.0K | $-261.0K | $10.0K | |
| Pretax Income | $-61M | $-39M | $-66M | $-67M | $-158M | $-94M | $-95M | $-91M | $-63M | $-112M | $-30M | $-3M | |
| Income Tax | $969.0K | $266.0K | $547.0K | $8.0K | $4.0K | $2.0K | $303.0K | $4.0K | $1M | · | $-29.0K | $67.0K | |
| Net Income | $-62M | $-39M | $-66M | $-67M | $-158M | $-94M | $-95M | $-91M | $-64M | $-112M | $-30M | $-3M | |
| EPS (Basic) | $-0.26 | $-0.17 | $-0.30 | $-0.42 | $-1.52 | $-1.05 | $-1.47 | · | · | · | · | · | |
| EPS (Diluted) | $-0.26 | $-0.17 | $-0.30 | $-0.42 | $-1.52 | $-1.05 | $-1.47 | · | · | · | · | · | |
| Shares (Basic) | 241,033,750 | 235,232,927 | 219,331,253 | 158,690,083 | 104,205,645 | 89,582,138 | 64,478,066 | · | · | · | · | · | |
| Shares (Diluted) | 241,033,750 | 235,232,927 | 219,331,253 | 158,690,083 | 104,205,645 | 89,582,138 | 64,478,066 | · | · | · | · | · | |
| EBITDA | $-38M | $-26M | $-62M | $-63M | $-154M | $-91M | $-91M | $-91M | $-65M | $-113M | $-29M | · |
Bilans
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $68M | $65M | $21M | $96M | $72M | $91M | $181M | $79M | $75M | $75M | $107M | $107M | |
| Receivables | $72M | $58M | $22M | $8M | $502.0K | $0 | · | · | · | · | · | $3M | |
| Inventory | $123M | $91M | $49M | $28M | $0 | · | · | · | · | · | · | · | |
| Prepaid Expense | $14M | $11M | $8M | $5M | $7M | $8M | $4M | $3M | $5M | $3M | $5M | $1M | |
| Current Assets | $382M | $356M | $246M | $154M | $134M | $195M | $252M | $176M | $150M | $204M | $112M | $111M | |
| PP&E (Net) | $2M | $1M | $1M | $1M | $2M | $2M | $3M | $6M | $8M | $9M | $5M | $2M | |
| PP&E (Gross) | $5M | $12M | $11M | $11M | $18M | $16M | $16M | $16M | $16M | $14M | $9M | $6M | |
| Accum. Depreciation | $3M | $11M | $10M | $10M | $16M | $14M | $13M | $10M | $8M | $5M | $4M | $4M | |
| Other Non-current Assets | $7M | $5M | $4M | $881.0K | $1M | $552.0K | $314.0K | $1M | $159.0K | $148.0K | $104.0K | $104.0K | |
| Total Assets | $502M | $436M | $298M | $190M | $150M | $202M | $260M | $183M | $158M | $213M | $117M | $113M | |
| Accounts Payable | $19M | $16M | $11M | $11M | $4M | $6M | $2M | $1M | $4M | $6M | $3M | $3M | |
| Accrued Liabilities | · | · | · | · | · | · | · | $13M | $11M | $10M | $1M | · | |
| Current Liabilities | $89M | $78M | $50M | $66M | $53M | $28M | $22M | $18M | $18M | $19M | $8M | $22M | |
| Capital Leases | $4M | $1M | $2M | $6M | $10M | $413.0K | $2M | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | $0 | · | · | · | · | $720.0K | $779.0K | $322.0K | $122.0K | |
| Total Liabilities | $335M | $262M | $131M | $92M | $67M | $75M | $73M | $68M | $19M | $20M | $8M | $53M | |
| Long-term Debt | $203M | $151M | $50M | $27M | $32M | $51M | $50M | $52M | · | · | · | · | |
| Common Stock | $24.0K | $24.0K | $23.0K | $20.0K | $13.0K | $9.0K | $9.0K | $6.0K | $5.0K | $5.0K | $3.0K | $2.0K | |
| Retained Earnings | $-947M | $-885M | $-846M | $-780M | $-713M | $-555M | $-460M | $-366M | $-278M | $-214M | $-101M | $-72M | |
| AOCI | $198.0K | $57.0K | $224.0K | $-54.0K | $-6.0K | $-4.0K | $20.0K | $-38.0K | $-47.0K | $-71.0K | · | · | |
| Stockholders' Equity | $167M | $173M | $167M | $98M | $83M | $126M | $187M | $116M | $139M | $193M | $109M | $61M | |
| Liabilities + Equity | $502M | $436M | $298M | $190M | $150M | $202M | $260M | $183M | $158M | $213M | $117M | $113M | |
| Shares Outstanding | 244,351,501 | 238,015,825 | 232,453,190 | 198,575,016 | 130,182,535 | 93,599,975 | 88,817,741 | 62,516,627 | 47,534,979 | 47,309,422 | 25,964,886 | 18,589,245 |
Przepływy pieniężne
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $2M | $1M | $1M | $3M | $3M | $2M | $3M | $3M | $1M | $800.0K | $300.0K | |
| Stock-based Comp | $49M | $37M | $14M | $11M | $12M | $11M | $10M | $9M | $10M | $5M | $3M | $2M | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | $-30.0K | · | · | · | |
| Restructuring | · | · | · | · | $6M | · | · | · | · | · | · | · | |
| Other Non-cash | $-33M | $-45M | $-38M | $-15M | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-42M | $-45M | $-90M | $-70M | $-153M | $-81M | $-76M | $-70M | $-65M | $-93M | $-72M | $13M | |
| CapEx | $1M | $1M | $344.0K | $55.0K | $2M | $324.0K | $325.0K | $311.0K | $2M | $5M | $3M | $2M | |
| Investing Cash Flow | $-9M | $-18M | $-131M | $18M | $51M | $-31M | $23M | $-30M | $65M | $-131M | $-3M | · | |
| Stock Issued | $0 | $0 | $119M | $72M | $101M | $21M | $0 | · | · | $191M | $74M | $61M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | $2.0K | |
| Net Stock Activity | $0 | $0 | $119M | $72M | $101M | · | · | · | · | $191M | $74M | · | |
| Financing Cash Flow | $55M | $107M | $146M | $75M | $83M | $23M | $155M | $104M | $685.0K | $191M | $75M | · | |
| Net Change in Cash | $3M | $43M | $-75M | $24M | $-19M | $-90M | $102M | $3M | $785.0K | $-32M | $-282.0K | $73M | |
| Taxes Paid | $485.0K | $266.0K | $51.0K | $6.0K | $4.0K | $1.0K | $2.0K | $4.0K | $3.0K | · | $69.0K | · | |
| Free Cash Flow | $-44M | $-46M | $-90M | $-70M | $-154M | $-82M | $-77M | $-71M | $-68M | $-97M | $-75M | · | |
| Levered FCF | · | · | $-95M | $-73M | $-159M | $-87M | $-83M | $-74M | · | · | · | · |
Rentowność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | 88.6% | 82.1% | 80.0% | · | · | · | |
| Operating Margin | -10.1% | -8.4% | -50.8% | -122.2% | -1528.6% | -1199.1% | -1728.1% | -3488.6% | -155.0% | · | -122.3% | · | |
| Net Margin | -15.1% | -11.7% | -53.1% | -128.8% | -1566.5% | -1245.7% | -1797.8% | -3502.0% | -153.2% | · | -123.3% | · | |
| Pretax Margin | -14.9% | -11.7% | -52.6% | -128.8% | -1566.4% | -1245.7% | -1792.0% | -3501.9% | -150.4% | · | -123.4% | · | |
| EBITDA Margin | -9.3% | -7.8% | -49.8% | -120.0% | -1528.6% | -1199.1% | -1728.1% | -3488.6% | -155.0% | · | -122.3% | · | |
| ROA | -13.1% | -10.7% | -27.1% | -39.5% | -90.0% | -40.9% | -42.9% | -53.5% | -34.7% | -68.1% | -25.7% | · | |
| ROE | -40.2% | -23.6% | -36.9% | -81.4% | -192.8% | -73.3% | -80.5% | -71.0% | -38.7% | -74.4% | -34.9% | · | |
| ROIC | -24.9% | -16.2% | -38.2% | -64.8% | -186.8% | -72.0% | -49.0% | -78.5% | -47.6% | · | -27.0% | · |
Płynność i wypłacalność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.3 | 4.6 | 4.9 | 2.3 | 2.5 | 6.9 | 11.3 | 9.9 | 8.4 | 10.6 | 14.5 | · | |
| Quick Ratio | 1.6 | 1.6 | 0.9 | 1.6 | 1.4 | 3.2 | 8.2 | 4.4 | 4.2 | 3.9 | 13.9 | · | |
| Interest Coverage | · | · | -12.8 | -18.8 | -34.3 | -17.8 | -15.9 | -25.7 | · | · | · | · |
Efektywność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.9 | 0.9 | 0.5 | 0.3 | 0.1 | 0.0 | 0.0 | 0.0 | 0.2 | · | 0.2 | · | |
| Inventory Turnover | 0.4 | 0.7 | 0.5 | 0.3 | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 6.3 | 8.4 | 8.4 | 12.7 | 40.2 | · | · | · | · | · | · | · |
Na akcję
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.68 | $0.73 | $0.72 | $0.50 | $0.63 | $1.35 | $2.10 | $1.85 | $2.93 | $4.08 | $4.19 | · | |
| Revenue / Share | $1.69 | $1.42 | $0.57 | $0.33 | $0.10 | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-0.18 | $-0.19 | $-0.41 | $-0.44 | $-1.46 | · | · | · | · | · | · | · | |
| Cash / Share | $0.28 | $0.27 | $0.09 | $0.48 | $0.56 | $0.97 | $2.04 | $1.26 | $1.59 | $1.58 | $4.12 | · | |
| EPS (TTM) | $-0.26 | $-0.17 | $-0.30 | $-0.42 | $-1.52 | $-1.05 | $-1.47 | $-1.36 | $-1.36 | $-1.76 | $-1.12 | $-2.47 |
Stopy Wzrostu
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 22.1% | 168.1% | 138.6% | 416.6% | 33.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 98.4% | 220.9% | 154.3% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 121.9% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM)
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $407M | $334M | $124M | $52M | $10M | $8M | $5M | $3M | $42M | $38M | $24M | $32M | |
| Net Income TTM | $-62M | $-39M | $-66M | $-67M | $-158M | $-94M | $-95M | $-91M | $-64M | $-112M | $-30M | $-3M | |
| Market Cap | $1.42B | $1.21B | $1.44B | $566M | $143M | $606M | $667M | $112M | $314M | $672M | $470M | · | |
| P/E | -22.4 | -29.8 | -20.7 | -6.8 | -0.7 | -6.2 | -5.1 | -1.3 | -4.9 | -8.1 | -16.2 | -7.6 | |
| P/S | 3.5 | 3.6 | 11.6 | 10.9 | 14.2 | 80.0 | 126.2 | 42.9 | 7.5 | 17.7 | 19.6 | · | |
| P/B | 8.5 | 7.0 | 8.6 | 5.8 | 1.7 | 4.8 | 3.6 | 1.0 | 2.3 | 3.5 | 4.3 | · | |
| P / Tangible Book | 8.5 | 7.0 | 8.6 | 5.8 | 1.7 | 4.8 | · | · | · | · | · | · | |
| P / Cash Flow | -33.5 | -26.9 | -16.1 | -8.1 | -0.9 | -7.4 | -8.7 | -1.6 | -4.8 | -7.3 | -6.5 | · | |
| P / FCF | -32.4 | -26.3 | -16.0 | -8.1 | -0.9 | -7.4 | -8.7 | -1.6 | -4.6 | -6.9 | -6.2 | · | |
| Earnings Yield | -4.5% | -3.4% | -4.8% | -14.7% | -138.2% | -16.2% | -19.6% | -76.0% | -20.6% | -12.4% | -6.2% | -13.1% |
Rachunek zysków i strat
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $121M | $94M | $125M | $110M | $98M | $74M | $116M | $98M | $73M | $46M | $34M | $56M | $22M | $11M | $44M | $5M | |
| Cost of Revenue | $6M | $5M | $11M | $4M | $12M | $12M | $18M | $16M | $9M | $7M | $5M | $8M | $3M | $2M | $3M | $732.0K | |
| R&D Expense | $26M | $20M | $23M | $18M | $16M | $15M | $14M | $15M | $13M | $11M | $10M | $9M | $8M | $9M | $9M | $7M | |
| SG&A Expense | $101M | $102M | $86M | $84M | $84M | $83M | $76M | $65M | $65M | $53M | $48M | $33M | $27M | $27M | $20M | $19M | |
| Operating Expenses | $133M | $127M | $149M | $102M | $112M | $110M | $140M | $80M | $77M | $64M | $75M | $41M | $35M | $36M | $29M | $26M | |
| Operating Income | $-12M | $-33M | $5M | $5M | $-14M | $-36M | $8M | $2M | $-14M | $-25M | $-28M | $7M | $-17M | $-26M | $12M | $-22M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $2M | · | $1M | $1M | $1M | · | $886.0K | |
| Other Non-op | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $2M | $1M | $375.0K | $704.0K | |
| Pretax Income | $-17M | $-38M | $-400.0K | $-867.0K | $-19M | $-40M | $5M | $-766.0K | $-16M | $-26M | $-28M | $7M | $-17M | $-27M | $11M | $-23M | |
| Income Tax | $110.0K | $8.0K | $7.0K | $102.0K | $1.0K | $859.0K | $35.0K | $43.0K | $67.0K | $121.0K | $333.0K | $200.0K | $0 | $14.0K | $0 | $0 | |
| Net Income | $-17M | $-38M | $-407.0K | $-969.0K | $-19M | $-41M | $5M | $-809.0K | $-16M | $-27M | $-29M | $7M | $-17M | $-27M | $11M | $-23M | |
| EPS (Basic) | $-0.07 | $-0.15 | $-0.01 | $0.00 | $-0.08 | $-0.17 | $0.01 | $0.00 | $-0.07 | $-0.11 | $-0.12 | $0.03 | $-0.08 | $-0.13 | $0.12 | $-0.14 | |
| EPS (Diluted) | $-0.07 | $-0.15 | $-0.01 | $0.00 | $-0.08 | $-0.17 | $0.01 | $0.00 | $-0.07 | $-0.11 | $-0.12 | $0.03 | $-0.08 | $-0.13 | $0.12 | $-0.14 | |
| Shares (Basic) | 248,067,253 | 245,855,082 | · | 241,908,407 | 239,928,570 | 238,624,145 | · | 235,911,399 | 234,571,192 | 233,065,960 | · | 222,782,229 | 214,951,127 | 207,023,127 | · | 165,104,789 | |
| Shares (Diluted) | 248,067,253 | 245,855,082 | · | 241,908,407 | 239,928,570 | 238,624,145 | · | 235,911,399 | 234,571,192 | 233,065,960 | · | 227,894,335 | 214,951,127 | 207,023,127 | · | 165,104,789 | |
| EBITDA | $-12M | $-32M | · | $5M | $-14M | $-36M | · | $2M | $-14M | $-24M | · | $7M | $-17M | $-26M | · | $-22M |
Bilans
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $97M | $31M | $68M | $43M | $90M | $31M | $65M | $47M | $42M | $36M | · | $34M | $30M | $92M | · | $62M | |
| Receivables | $100M | $83M | $72M | $77M | $63M | $46M | $58M | $53M | $37M | $28M | · | $43M | $9M | $12M | · | $5M | |
| Inventory | $139M | $128M | $123M | $129M | $123M | $106M | $91M | $85M | $83M | $79M | · | $47M | $48M | $45M | · | $10M | |
| Prepaid Expense | $19M | $24M | $14M | $15M | $16M | $15M | $11M | $12M | $11M | $12M | · | $7M | $5M | $6M | · | $7M | |
| Current Assets | $442M | $382M | $382M | $368M | $352M | $313M | $356M | $284M | $263M | $258M | · | $241M | $162M | $167M | · | $120M | |
| PP&E (Net) | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | · | $1M | $1M | $1M | · | $1M | |
| PP&E (Gross) | · | · | $5M | · | · | · | $12M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $3M | · | · | · | $11M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $7M | $7M | $7M | $7M | $7M | $7M | $5M | $5M | $5M | $6M | · | $2M | $673.0K | $774.0K | · | $13M | |
| Total Assets | $576M | $505M | $502M | $486M | $467M | $410M | $436M | $368M | $343M | $342M | · | $289M | $211M | $217M | · | $145M | |
| Accounts Payable | $38M | $28M | $19M | $18M | $22M | $14M | $16M | $16M | $11M | $17M | · | $8M | $5M | $11M | · | $3M | |
| Current Liabilities | $132M | $110M | $89M | $83M | $82M | $76M | $78M | $70M | $62M | $57M | · | $44M | $62M | $63M | · | $52M | |
| Capital Leases | $3M | $3M | $4M | $4M | $4M | $3M | $1M | $1M | $1M | $778.0K | · | $3M | $4M | $5M | · | $7M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | $170.0K | $172.0K | · | · | · | |
| Total Liabilities | $427M | $356M | $335M | $332M | $327M | $265M | $262M | $210M | $196M | $191M | · | $98M | $88M | $92M | · | $78M | |
| Long-term Debt | $252M | $204M | $203M | $202M | $201M | $151M | $151M | $101M | $100M | $100M | · | $27M | $27M | $27M | · | $27M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $27M | |
| Common Stock | $25.0K | $25.0K | $24.0K | $24.0K | $24.0K | $24.0K | $24.0K | $24.0K | $23.0K | $23.0K | · | $23.0K | $22.0K | $21.0K | · | $19.0K | |
| Retained Earnings | $-1.00B | $-985M | $-947M | $-947M | $-946M | $-926M | $-885M | $-890M | $-889M | $-873M | · | $-817M | $-824M | $-807M | · | $-791M | |
| AOCI | $-193.0K | $-124.0K | $198.0K | $124.0K | $-38.0K | $18.0K | $57.0K | $185.0K | $-101.0K | $-20.0K | · | $-201.0K | $-210.0K | $-20.0K | · | $-114.0K | |
| Stockholders' Equity | $149M | $149M | $167M | $154M | $140M | $146M | $173M | $158M | $147M | $151M | $167M | $191M | $123M | $125M | $98M | $67M | |
| Liabilities + Equity | $576M | $505M | $502M | $486M | $467M | $410M | $436M | $368M | $343M | $342M | · | $289M | $211M | $217M | · | $145M | |
| Shares Outstanding | 249,147,061 | 246,973,414 | 244,351,501 | 242,971,838 | 240,765,516 | 239,201,256 | 238,015,825 | 236,890,431 | 235,401,398 | 233,959,744 | · | 232,133,132 | 217,862,921 | 214,462,050 | · | 187,399,645 |
Przepływy pieniężne
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $604.0K | $915.0K | $921.0K | $905.0K | $631.0K | $602.0K | $515.0K | $544.0K | $569.0K | $435.0K | $362.0K | $291.0K | $642.0K | $-3.0K | $127.0K | $279.0K | |
| Stock-based Comp | $15M | $14M | $12M | $13M | $12M | $12M | $10M | $9M | $11M | $8M | $4M | $3M | $3M | $3M | $2M | $2M | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Other Non-cash | · | $-10M | · | · | · | $-10M | · | · | · | $-17M | · | · | · | $-21M | · | · | |
| Operating Cash Flow | $-6M | $-32M | $21M | $365.0K | $-25M | $-38M | $10M | $501.0K | $-19M | $-36M | $-9M | $-21M | $-15M | $-45M | $14M | $-25M | |
| CapEx | $13.0K | $69.0K | $361.0K | $156.0K | $650.0K | $325.0K | $593.0K | $137.0K | $131.0K | $150.0K | $43.0K | $194.0K | $93.0K | $14.0K | $55.0K | $0 | |
| Investing Cash Flow | $23M | $-10M | $4M | $-51M | $35M | $3M | $-42M | $2M | $24M | $-3M | $-30M | $-33M | $-59M | $-10M | $1M | $-832.0K | |
| Stock Issued | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $-12.0K | $57M | $11M | $51M | $19M | $34M | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $51M | · | · | |
| Financing Cash Flow | $50M | $5M | $557.0K | $3M | $50M | $1M | $49M | $3M | $2M | $53M | $26M | $58M | $12M | $51M | $19M | $34M | |
| Net Change in Cash | $66M | $-37M | $25M | $-47M | $59M | $-34M | $18M | $6M | $6M | $15M | $-12M | $4M | $-62M | $-4M | $35M | $8M | |
| Taxes Paid | $170.0K | $-69.0K | $-6.0K | $51.0K | $438.0K | $2.0K | $-6.0K | $0 | $271.0K | $1.0K | $32.0K | $0 | $19.0K | $0 | $0 | $0 | |
| Free Cash Flow | · | $-32M | · | · | · | $-39M | · | · | · | $-36M | · | · | · | $-45M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-38M | · | · | · | $-46M | · | · |
Rentowność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -10.3% | -34.7% | · | 4.2% | -14.7% | -49.0% | · | 2.3% | -18.6% | -53.6% | · | 13.1% | -74.4% | -229.2% | · | -438.8% | |
| Net Margin | -13.8% | -39.8% | · | -0.88% | -19.5% | -55.5% | · | -0.82% | -22.5% | -57.6% | · | 11.8% | -76.7% | -235.5% | · | -459.1% | |
| Pretax Margin | -13.7% | -39.8% | · | -0.79% | -19.5% | -54.4% | · | -0.78% | -22.4% | -57.4% | · | 12.1% | -76.7% | -235.4% | · | -459.1% | |
| EBITDA Margin | -10.3% | -33.7% | · | 4.2% | -14.7% | -48.2% | · | 2.3% | -18.6% | -52.7% | · | 13.1% | -74.4% | -229.3% | · | -438.8% | |
| ROA | -3.2% | -8.2% | · | -0.23% | -4.7% | -10.9% | · | -0.25% | -5.9% | -9.5% | · | 3.0% | -10.0% | -15.5% | · | -14.5% | |
| ROE | -11.6% | -25.6% | · | -0.62% | -13.3% | -27.8% | · | -0.46% | -12.2% | -19.2% | · | 5.1% | -19.4% | -28.2% | · | -30.9% | |
| ROIC | -8.4% | -22.1% | · | 3.4% | -10.3% | -25.5% | · | 1.5% | -9.3% | -16.4% | · | 3.8% | -13.5% | -20.8% | · | -23.4% |
Płynność i wypłacalność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.3 | 3.5 | · | 4.4 | 4.3 | 4.1 | · | 4.0 | 4.2 | 4.5 | · | 5.5 | 2.6 | 2.6 | · | 2.3 | |
| Quick Ratio | 1.5 | 1.0 | · | 1.4 | 1.9 | 1.0 | · | 1.4 | 1.3 | 1.1 | · | 1.8 | 0.6 | 1.7 | · | 1.3 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.4 | |
| LT Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -10.5 | · | 6.7 | -15.5 | -25.4 | · | -24.7 |
Efektywność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.3 | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.2 | · | 0.3 | 0.1 | 0.1 | · | 0.0 | |
| Inventory Turnover | 0.0 | 0.0 | · | 0.0 | 0.1 | 0.1 | · | 0.2 | 0.1 | 0.1 | · | 0.3 | 0.1 | 0.1 | · | 0.1 | |
| Receivables Turnover | 1.5 | 1.5 | · | 1.7 | 2.0 | 2.0 | · | 2.0 | 3.2 | 2.3 | · | 2.3 | 3.0 | 1.4 | · | 1.8 |
Na akcję
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.60 | $0.60 | · | $0.64 | $0.58 | $0.61 | · | $0.67 | $0.62 | $0.64 | · | $0.82 | $0.57 | $0.58 | · | $0.36 | |
| Revenue / Share | $0.49 | $0.38 | · | $0.46 | $0.41 | $0.31 | · | $0.42 | $0.31 | $0.20 | · | $0.25 | $0.10 | $0.05 | · | $0.03 | |
| Cash Flow / Share | · | $-0.13 | · | · | · | $-0.16 | · | · | · | $-0.15 | · | · | · | $-0.22 | · | · | |
| Cash / Share | $0.39 | $0.13 | · | $0.18 | $0.37 | $0.13 | · | $0.20 | $0.18 | $0.15 | · | $0.15 | $0.14 | $0.43 | · | $0.33 | |
| EPS (TTM) | $-0.23 | $-0.24 | · | $-0.24 | $-0.24 | $-0.23 | · | $-0.30 | $-0.27 | $-0.28 | · | $-0.06 | $-0.23 | $-0.34 | · | $-0.85 |
Wycena (TTM)
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $451M | $428M | · | $398M | $386M | $362M | · | $252M | $210M | $159M | · | $134M | $83M | $63M | · | $9M | |
| Net Income TTM | $-56M | $-58M | · | $-57M | $-56M | $-54M | · | $-73M | $-65M | $-66M | · | $-27M | $-56M | $-66M | · | $-114M | |
| Market Cap | $1.27B | $1.48B | · | $1.34B | $944M | $1.17B | · | $1.63B | $1.74B | $1.71B | · | $947M | $739M | $1.03B | · | $223M | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $188M | |
| P/E | -22.2 | -25.0 | · | -23.0 | -16.3 | -21.3 | · | -23.0 | -27.4 | -26.1 | · | -68.0 | -14.7 | -14.1 | · | -1.4 | |
| P/S | 2.8 | 3.5 | · | 3.4 | 2.4 | 3.2 | · | 6.5 | 8.3 | 10.7 | · | 7.1 | 8.9 | 16.3 | · | 24.8 | |
| P/B | 8.5 | 10.0 | · | 8.7 | 6.8 | 8.1 | · | 10.3 | 11.9 | 11.3 | · | 5.0 | 6.0 | 8.2 | · | 3.3 | |
| P / Tangible Book | 8.5 | 10.0 | · | 8.7 | 6.8 | 8.1 | · | 10.3 | 11.9 | 11.3 | · | 5.0 | 6.0 | 8.2 | · | 3.3 | |
| P / Cash Flow | · | -45.9 | · | · | · | -30.5 | · | · | · | -47.8 | · | · | · | -22.9 | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 20.9 | |
| Earnings Yield | -4.5% | -4.0% | · | -4.4% | -6.1% | -4.7% | · | -4.3% | -3.6% | -3.8% | · | -1.5% | -6.8% | -7.1% | · | -71.4% |
Najnowszy okres po lewej · wartości null pokazane jako ·
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Przychody | $407M | $334M | $124M | $52M | $10M |
| Marża Operacyjna % | -10.1% | -8.4% | -50.8% | -122.2% | -1528.6% |
| Zysk netto | $-62M | $-39M | $-66M | $-67M | $-158M |
| Rozwodniony EPS | $-0.26 | $-0.17 | $-0.30 | $-0.42 | $-1.52 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 4.3 | 4.6 | 4.9 | 2.3 | 2.5 |
| Wskaźnik Szybkości | 1.6 | 1.6 | 0.9 | 1.6 | 1.4 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-44M | $-46M | $-90M | $-70M | $-154M |
Właściciele instytucjonalni (13F) 271 emitentów · $1.1B łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Posiadacze
271
Wartość posiadanych akcji
$1.1B
Nowe pozycje
44
Zamknięte pozycje
32
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 44 (-12 vs poprzedni kw.) | 32 (+1 vs poprzedni kw.) | 86 (-20 vs poprzedni kw.) | 89 (+30 vs poprzedni kw.) | +2.3M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| BlackRock, Inc. | $119 873 615 | 23 504 630 | 11,30% | Akcje |
| VANGUARD GROUP INC | $110 650 386 | 18 979 483 | 10,43% | Akcje |
| Rubric Capital Management LP | $82 633 770 | 16 202 700 | 7,79% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $70 893 942 | 13 900 773 | 6,68% | Akcje |
| STATE STREET CORP | $68 116 253 | 13 356 128 | 6,42% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $53 404 619 | 10 471 494 | 5,03% | Akcje |
| JANUS HENDERSON GROUP PLC | $50 143 692 | 8 371 234 | 4,73% | Akcje |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $48 688 000 | 9 546 732 | 4,59% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $40 936 547 | 8 026 774 | 3,86% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $32 655 404 | 6 401 736 | 3,08% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $26 570 097 | 5 209 823 | 2,50% | Akcje |
| Nuveen, LLC | $20 385 205 | 3 997 099 | 1,92% | Akcje |
| GOLDMAN SACHS GROUP INC | $18 793 673 | 3 685 034 | 1,77% | Akcje |
| AIGH Capital Management LLC | $16 320 000 | 3 200 000 | 1,54% | Akcje |
| MORGAN STANLEY | $12 186 687 | 2 389 546 | 1,15% | Akcje |
| AQR CAPITAL MANAGEMENT LLC | $11 812 722 | 2 316 220 | 1,11% | Akcje |
| NORTHERN TRUST CORP | $11 628 729 | 2 280 143 | 1,10% | Akcje |
| Rock Springs Capital Management LP | $11 433 022 | 2 241 769 | 1,08% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $11 279 976 | 2 211 760 | 1,06% | Akcje |
| BANK OF AMERICA CORP /DE/ | $11 033 851 | 2 163 500 | 1,04% | Akcje |
| ORACLE INVESTMENT MANAGEMENT INC | $10 917 398 | 1 872 624 | 1,03% | Akcje |
| Qube Research & Technologies Ltd | $10 662 443 | 2 090 675 | 1,00% | Akcje |
| JONES FINANCIAL COMPANIES LLLP | $9 800 923 | 1 765 932 | 0,92% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $8 949 577 | 1 754 819 | 0,84% | Akcje |
| Eversept Partners, LP | $8 559 560 | 1 678 345 | 0,81% | Akcje |
| J. Goldman & Co LP | $8 057 123 | 1 579 828 | 0,76% | Akcje |
| TWO SIGMA ADVISERS, LP | $7 862 921 | 1 348 700 | 0,74% | Akcje |
| Invesco Ltd. | $6 981 226 | 1 368 868 | 0,66% | Akcje |
| FIRST TRUST ADVISORS LP | $6 638 282 | 1 301 624 | 0,63% | Akcje |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $6 073 275 | 1 161 238 | 0,57% | Akcje |
| CITADEL ADVISORS LLC | $5 253 887 | 1 030 174 | 0,50% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $4 671 789 | 916 037 | 0,44% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $4 552 224 | 892 593 | 0,43% | Akcje |
| PANAGORA ASSET MANAGEMENT INC | $4 543 814 | 890 944 | 0,43% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $4 132 642 | 810 322 | 0,39% | Akcje |
| DEUTSCHE BANK AG\ | $3 931 642 | 770 910 | 0,37% | Akcje |
| ExodusPoint Capital Management, LP | $3 839 907 | 752 923 | 0,36% | Akcje |
| Bank of New York Mellon Corp | $3 823 350 | 749 676 | 0,36% | Akcje |
| Squarepoint Ops LLC | $3 647 836 | 715 262 | 0,34% | Akcje |
| SECTOR GAMMA AS | $3 502 904 | 686 844 | 0,33% | Akcje |
| Trexquant Investment LP | $3 368 989 | 660 586 | 0,32% | Akcje |
| Redmile Group, LLC | $3 272 925 | 641 750 | 0,31% | Akcje |
| Cubist Systematic Strategies, LLC | $3 139 766 | 569 831 | 0,30% | Akcje |
| RAYMOND JAMES FINANCIAL INC | $2 869 627 | 562 672 | 0,27% | Akcje |
| UBS Group AG | $2 813 778 | 551 721 | 0,27% | Akcje |
| Jump Financial, LLC | $2 738 604 | 536 981 | 0,26% | Akcje |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $2 639 638 | 440 674 | 0,25% | Akcje |
| MACKENZIE FINANCIAL CORP | $2 417 879 | 474 094 | 0,23% | Akcje |
| Swiss National Bank | $2 384 760 | 467 600 | 0,22% | Akcje |
| HUSSMAN STRATEGIC ADVISORS, INC. | $2 142 000 | 420 000 | 0,20% | Akcje |
Aktywiści i właściciele 5%+ 2 akcje
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| 29 grudnia 2021 | · | Pierwotne zgłoszenie | · | SEC | |
| New Enterprise Associates 12, Limited Partnership, New Enterprise Associates 15, L.P., NEA 15 Opportunity Fund, L.P., NEA Partners 12, Limited Partnership, NEA Partners 15, L.P., NEA Partners 15-OF, L.P., NEA 12 GP, LLC, NEA 15 GP, LLC, Forest Baskett, Anthony A. Florence, Jr., Patrick J. Kerins, Mohamad H. Makhzoumi, Joshua Makower, Scott D. Sandell, Peter W. Sonsini ×7 zgłoszenia | 18 czerwca 2020 | · | Pierwotne zgłoszenie | Inwestycja pasywna | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insiderzy spółki 49 insiderów · 21 dyrektorzy generalni · 13 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Michael Raab | President & CEO | 21 sierpnia 2026 S | 1 619 792 | 0 | 20 | $-2 572 734 |
| Susan Hohenleitner | Chief Financial Officer | 21 sierpnia 2026 S | 227 520 | 0 | 4 | $-27 013 |
| Justin A Renz | Chief Financial Officer | 21 sierpnia 2025 S | 409 052 | 0 | 0 | $0 |
| Mark Kaufmann | Chief Financial Officer | 7 października 2019 M | 141 418 | 0 | 0 | $0 |
| Reginald Seeto | Chief Operating Officer | 16 stycznia 2018 A | 149 885 | 0 | 0 | $0 |
| James Parker Brady | Chief Human Resources Officer | 21 sierpnia 2026 S | 245 930 | 0 | 5 | $-84 854 |
| Joseph James Reilly | Senior Vice President and Chief Accounting Officer | 21 sierpnia 2026 S | 145 854 | 0 | 8 | $-129 261 |
| Eric Duane Foster | Chief Commercial Officer | 21 sierpnia 2026 S | 409 410 | 0 | 11 | $-176 390 |
| Mike Kelliher | Chief Business Officer | 21 sierpnia 2026 S | 349 660 | 0 | 10 | $-162 245 |
| Laura A Williams | Chief Patient Officer | 21 sierpnia 2026 S | 367 456 | 0 | 13 | $-1 008 207 |
| John E Bishop | Chief Technical and Quality Officer | 21 sierpnia 2026 S | 317 095 | 0 | 6 | $-109 265 |
| Elizabeth A Grammer | Chief Legal and Administrative Officer | 21 listopada 2025 S | 299 895 | 0 | 1 | $-33 212 |
| Robert Blanks | Chief Regulatory and Quality Affairs Officer | 20 listopada 2024 S | 314 421 | 0 | 0 | $0 |
| David P. Rosenbaum | Chief Development Officer | 20 listopada 2024 S | 151 373 | 0 | 0 | $0 |
| Robert Ora Felsch | SVP Finance and Chief Accounting Officer | 20 sierpnia 2024 S | 91 560 | 0 | 0 | $0 |
| Susan Rodriguez | Chief Commercial Officer | 21 maja 2024 S | 449 092 | 0 | 0 | $0 |
| Jeffrey W Jacobs | Chief Scientific Officer | 22 listopada 2021 S | 119 483 | 0 | 0 | $0 |
| Jeremy S Caldwell | EVP, Chief Scientific Officer | 16 stycznia 2018 A | 44 497 | 0 | 0 | $0 |
| Paul Korner | EVP, Chief Medical Officer | 19 stycznia 2017 A | 72 608 | 0 | 0 | $0 |
| Narani Arasaratnam | VP, Corporate Controller | 15 stycznia 2016 A | 1 232 | 0 | 0 | $0 |
| George Jue | VP, Operations | 2 marca 2015 S | 24 134 | 0 | 0 | $0 |
| Muna Bhanji | Dyrektor | 16 czerwca 2026 A | 163 808 | 0 | 0 | $0 |
| Onaiza Cadoret-Manier | Dyrektor | 16 czerwca 2026 A | 178 156 | 0 | 0 | $0 |
| Merdad Parsey | Dyrektor | 16 czerwca 2026 A | 83 746 | 0 | 0 | $0 |
| Robert B Bazemore | Dyrektor | 16 czerwca 2026 A | 68 006 | 0 | 0 | $0 |
| Richard J Rodgers | Dyrektor | 16 czerwca 2026 A | 439 998 | 0 | 0 | $0 |
| William C Bertrand JR | Dyrektor | 16 czerwca 2026 A | 329 507 | 0 | 0 | $0 |
| David M Mott | Dyrektor | 16 czerwca 2026 A | 3 349 655 | 1 | 0 | $1 946 665 |
| Geoffrey A. Block | Dyrektor | 15 czerwca 2023 A | · | 0 | 0 | $0 |
| Jan M Lundberg | Dyrektor | 15 czerwca 2023 A | 146 794 | 0 | 0 | $0 |
| Gordon Ringold | Dyrektor | 9 czerwca 2020 A | 25 000 | 0 | 0 | $0 |
| Annalisa Jenkins | Dyrektor | 13 czerwca 2019 A | 33 471 | 0 | 0 | $0 |
| Peter G Schultz | Dyrektor | 11 czerwca 2015 A | 910 339 | 0 | 0 | $0 |
| Forest Baskett | Posiadacz 10% | 15 grudnia 2021 S | 2 258 850 | 0 | 0 | $0 |
| Scott D. Sandell | Posiadacz 10% | 15 grudnia 2021 S | 2 258 850 | 0 | 0 | $0 |
| New Enterprise Associates 12, Limited Partnership | Posiadacz 10% | 10 czerwca 2020 J | 8 086 401 | 0 | 0 | $0 |
| Patrick J. Kerins | Posiadacz 10% | 10 czerwca 2020 J | 11 324 | 0 | 0 | $0 |
| NEA 15 GP, LLC | Posiadacz 10% | 9 grudnia 2019 A | 3 482 186 | 0 | 0 | $0 |
| Mohamad Makhzoumi | Posiadacz 10% | 9 grudnia 2019 A | 3 482 186 | 0 | 0 | $0 |
| Anthony A. Florence, Jr. | Posiadacz 10% | 9 grudnia 2019 A | 3 482 186 | 0 | 0 | $0 |
| Peter W. Sonsini | Posiadacz 10% | 9 grudnia 2019 A | 3 482 186 | 0 | 0 | $0 |
| Joshua Makower | Posiadacz 10% | 9 grudnia 2019 A | 3 482 186 | 0 | 0 | $0 |
| Peter J Barris | Posiadacz 10% | 9 grudnia 2019 A | 3 482 186 | 0 | 0 | $0 |
| Jon Sakoda | Posiadacz 10% | 25 maja 2018 A | 3 082 186 | 0 | 0 | $0 |
| Ravi Viswanathan | Posiadacz 10% | 25 maja 2018 A | 3 082 186 | 0 | 0 | $0 |
| James M Barrett | Posiadacz 10% | 25 maja 2018 A | 9 169 210 | 0 | 0 | $0 |
| Harry R Weller | Posiadacz 10% | 18 lipca 2016 P | 2 665 519 | 0 | 0 | $0 |
| Krishna Kittu Kolluri | Posiadacz 10% | 18 lipca 2016 P | 2 665 519 | 0 | 0 | $0 |
| Ryan D Drant | Posiadacz 10% | 5 czerwca 2015 P | 7 488 893 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Posiadanie ETF-ów Posiadane przez 28 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| PBE · Invesco Exchange-Traded Fund Trust | 2,53% | 3 104 336 SH | 2 października 2026 | Dziennie |
| BBP · ETFis Series Trust I | 1,20% | 238 515 NS | 31 lipca 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,26% | 688 275 NS | 31 lipca 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,25% | 252 024 NS | 31 lipca 2026 | N-PORT |
| ESSC · Strategy Shares | 0,16% | 11 542 NS | 31 lipca 2026 | N-PORT |
| PWS · Pacer Funds Trust | 0,07% | 3 443 NS | 31 lipca 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,07% | 262 064 SH | 19 sierpnia 2026 | Dziennie |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,06% | 171 046 NS | 31 lipca 2026 | N-PORT |
| IWO · iShares Trust | 0,06% | 2 295 024 SH | 11 września 2026 | Dziennie |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,06% | 17 737 SH | 2 października 2026 | Dziennie |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,05% | 62 351 NS | 31 lipca 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,04% | 62 620 NS | 31 lipca 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,04% | 1 406 578 SH | 19 sierpnia 2026 | Dziennie |
| IWM · iShares Trust | 0,03% | 6 245 888 SH | 11 września 2026 | Dziennie |
| VFMO · VANGUARD WELLINGTON FUND | 0,02% | 86 948 SH | 19 sierpnia 2026 | Dziennie |
| VHT · VANGUARD WORLD FUND | 0,02% | 701 169 SH | 19 sierpnia 2026 | Dziennie |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,02% | 136 965 SH | 2 października 2026 | Dziennie |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 108 980 NS | 31 lipca 2026 | N-PORT |
| ISCG · iShares Trust | 0,02% | 41 902 SH | 11 września 2026 | Dziennie |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 2 830 493 SH | 19 sierpnia 2026 | Dziennie |
| WSML · iShares Trust | 0,01% | 14 381 SH | 11 września 2026 | Dziennie |
| TILT · FlexShares Trust | 0,00% | 17 234 NS | 31 lipca 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 365 988 SH | 11 września 2026 | Dziennie |
| IWV · iShares Trust | 0,00% | 57 560 SH | 11 września 2026 | Dziennie |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 7 404 867 SH | 19 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 19 726 SH | 19 sierpnia 2026 | Dziennie |
| ISCB · iShares Trust | · | 10 655 SH | 11 września 2026 | Dziennie |
| ISCV · iShares Trust | · | 23 168 SH | 11 września 2026 | Dziennie |
ARDX Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
ocena · 18 analityków
MOCNE KUPNO
Średni cel
$13.50
+304,2%
10 55,6%
Mocne kupno
7 38,9%
Kup
1 5,6%
Trzymaj
0 0,0%
Sprzedaj
0 0,0%
Mocna sprzedaż
12-miesięczny cel cenowy
10 analityków · 2026-10-02Średnia cel $12.90 +286,2%
← Poniżej wszystkich celów
Aktualna cena $3.34
Niski$8.00
Średnia$12.90
Wysoki$18.00
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
Podstawa R/R, ceny według zamknięcia z ostatniego końca roku obrotowego każdej spółki.
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| ARDX | $1.42B | -22.4 | 22.1% | -15.1% | -40.2% | · |
| GLUE | $1.03B | · | 63.5% | -31.2% | -15.4% | · |
| CRVS | $575M | -14.5 | · | · | -21.6% | · |
| RIGL | $784M | 2.2 | 64.1% | 124.7% | 155.1% | · |
| SANA | $1.09B | -4.2 | · | · | -172.3% | · |
| JBIO | $761M | -4.8 | · | · | -47.7% | · |
| OBX | · | · | · | · | · | · |
| ANNX | $750M | -3.7 | · | · | -100.7% | · |
| AVTX | $336M | -3.1 | -86.6% | -132642.4% | -83.4% | · |
| DSGN | $567M | -7.7 | · | · | -32.8% | · |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz wskaźniki, które są dla Ciebie ważne — kliknij + obok dowolnego wiersza w sekcji Pełne dane fundamentalne powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Źródło: SEC 10-Q złożone Sie 6, 2026